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The Public Health Crises of Chronic Pain
and Addiction
Rules and Values: A Coordinated Regulatory and Educational
Approach to the Public Health Crises of Chronic Pain
and Addiction
Joanna G. Katzman, MD, MSPH, George D. Comerci, MD, Michael Landen, MD, MPH, Larry Loring, RPh, Steven M. Jenkusky, MD, MA, Sanjeev Arora,
MD, Summers Kalishman, PhD, Lisa Marr, MD, Chris Camarata, MD, Daniel Duhigg, DO, MBA, Jennifer Dillow, MD, Eugene Koshkin, MD,
Denise E. Taylor, MD, and Cynthia M.A. Geppert, MD, PhD, MPH

Chronic pain and opioid addiction are 2 pressing public
health problems, and prescribing clinicians often lack
the skills necessary to manage these conditions. Our study
sought to address the benefits
of a coalition of an academic
medical center pain faculty
and government agencies in
addressing the high unintentional overdose death rates in
New Mexico.
New Mexico’s 2012–2013
mandated chronic pain and
addiction education programs
studied more than 1000 clinicians. Positive changes were
noted in precourse and postcourse surveys of knowledge,
self-efficacy, and attitudes.
Controlled substance dispensing data from the New
Mexico Board of Pharmacy
also demonstrated safer prescribing. The total morphine
and Valium milligram equivalents dispensed have decreased
continually since 2011. There
was also a concomitant decline
in total drug overdose deaths.
(Am J Public Health. 2014;104:
1356–1362. doi:10.2105/AJPH.
2014.301881)

PAIN IS A MAJOR PUBLIC
health issue.1---3 Chronic pain affects an estimated 100 million
Americans, which is more than the
number of citizens suffering from
cancer, diabetes, and all vascular
diseases combined.1 Chronic pain
costs up to $635 billion per year
in medical treatment and lost
productivity.1,4
Prescription opioid abuse is also
a major public health issue.5 The
2010 National Survey on Drug
Use and Health estimated that 35
million Americans (13.7%) adults
age 12 years and older had used
a pain reliever nonmedically at
least once in their lifetime.6 This is
an 18% increase since 2002. In
November 2011, the national
Morbidity and Mortality Weekly
Report reported 36 450 deaths
from drug overdoses in 2008.7
New Mexico and West Virginia
have had the highest rates of drug
overdose death in the United
States since 2008. Almost every
county in New Mexico has a
higher drug overdose death rate
than the rate for the entire United
States (12.1 per 100 000), with 2
counties (Rio Arriba and Mora) in
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New Mexico having overdose
death rates (67.4 per 100 000
and 65.0 per 100 000) at 5 times
the national rate7,8 (Figure 1).
During the 1990s, the undertreatment of pain, especially
among disadvantaged groups,
was ﬁrst identiﬁed as a deﬁciency
in medical practice and education.9 In response, academic
medical centers, state medical
boards, and accrediting agencies
stressed the need for pain to be
routinely assessed and effectively
treated, which led pharmaceutical
companies to aggressively market
opioids and other drugs for the
treatment of chronic pain.10 Over
the past decade there has been
a growing recognition that the
pendulum may have swung too
far, creating an unprecedented
epidemic of nonmedical use of
opioids, with deleterious effects
and—most notably—overdose
deaths.5,11 Primary care clinicians
who manage the majority of patients with chronic noncancer
pain and addiction struggle with
access to specialty care for these
patients and often lack the
knowledge and conﬁdence of best

practices in pain and addiction
treatment.12---18
State and federal legislators and
public health ofﬁcials faced with the
exponential and unprecedented
misuse of prescription drugs have
sought to control the problem in
large part through the passing of
new statutes and regulations governing the prescribing practices of
physicians and other health care
professionals. Unfortunately, these
and other rules-based approaches
could frequently have the unintended consequence of interfering
with the physician---patient relationship and undermining practitioners’
ability to follow the Hippocratic
Oath to “treat patients according to
my ability and judgment.”19
While additional training and
consultation is often a component
of these new state laws, New
Mexico realized that the number
of specialists available to provide
these services is insufﬁcient to
meet the need and thus chose to
adopt continuing education as
a cornerstone of its public health
policy. A unique coalition of the
University of New Mexico Health
Sciences Center (UNMHSC; the
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FIGURE 1—Drug overdose death rates by County: New Mexico, 2008–2012, and US, 2010.

only academic medical center in
the state); the New Mexico Department of Health; the New Mexico
Medical, Nursing, and Pharmacy
Boards; Project ECHO (Extension
for Community Healthcare Outcomes) Institute; and the New Mexico Veterans Affairs Health Care
System adopted a values-based educational approach as a primary
intervention utilized to improve
practitioner management of both
pain and addiction.
During the 2012 New Mexico
State Legislative Session, Senate
Bill 215 was adopted, which revised the Pain Relief Act of April 5,
1999, and required all health care
professional licensing boards to
mandate continuing medical education (CME) training in the treatment of chronic pain.20 The bill
also mandated the development of

a Governor’s Prescription Drug
Misuse and Overdose Prevention
and Pain Management Advisory
Council. The Governor’s Council
included representation from the
major stakeholders in the coalition.
The New Mexico Medical
Board (NMMB) developed
a working committee composed
of New Mexico Medical Board
members and UNMHSC pain
specialists. With input from the
public, the committee determined the optimal number of
CME hours that physicians and
physician assistants should receive. The committee recognized
that the epidemic of unintentional opioid overdoses and prescription medication misuse represented a true public health
emergency, and that emergency,
like other public health crises
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such as infectious disease outbreaks, warranted an immediate
response focused on practitioner
education.21
The New Mexico Medical Board
committee developed a consensus
on the CME topics to be covered
in these trainings:
a basic awareness of the epidemic
of chronic pain as well as opioid
abuse, addiction, and diversion;
d management of pain with nonopioid medications;
d Safer opioid prescribing;
d identiﬁcation and management
of patients at risk for addiction;
and
d current state and federal rules
and regulations including rules
regarding use of the prescription monitoring program
(PMP).22
d

On August 10, 2012, the
NMMB developed Rule 16.10.14,
requiring physicians and physician
assistants to complete 5 hours of
CME in pain and addiction between November 1, 2012, and
June 30, 2014. Additionally, the
NMMB mandated that all physicians and physician assistants sign
up with the New Mexico Board of
Pharmacy PMP and check the PMP
each time a new prescription for
chronic opioids is written and every 6 months thereafter.
Through the collaboration of
the Governor’s Prescription Drug
Misuse and Overdose Prevention
and Pain Management Advisory
Council, a number of health care
professional licensing boards—
including the nursing, pharmacy,
podiatry, and dentistry, as well as the
New Mexico Department of Health
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(for certiﬁed nurse-midwives)—in
New Mexico have now followed
the NMMB in mandating emergent, time-sensitive pain and addiction CME as well as pain-andaddiction CME requirements as
part of their individual board’s
renewal cycle.
Members of the faculty from the
UNMHSC Pain Center, Project
ECHO Pain, and the New Mexico
Veterans Affairs Health Care System, all of whom are experienced
pain practitioners and medical
educators, developed a half-day
course designed speciﬁcally to
fulﬁll the requirements of the
NMMB. These courses are
a means of bringing academic
expertise and specialist consultation to address the public
health crises of unintentional
overdose and chronic pain in
New Mexico.

THE CONTINUING
MEDICAL EDUCATION
COURSE
The CME course is designed to
satisfy the New Mexico Medical
Board 5-hour requirements on
pain management. Topics included in the course are
an overview of the prescription
opioid crisis nationally and
statewide,
d safe opioid prescribing,
d the use of nonopioid medications
in pain management,
d pediatric and adolescent pain
diagnosis and treatment,
d opioid misuse and addiction,
and
d federal and state regulations
pertaining to pain prescribing,
including the new state law.

In addition to didactic presentations, the course allows participants to choose to attend 2 of 4
workshops offered relating to
pediatric and adolescent pain,
safe opioid prescribing,
d treatment of the patient who is
misusing opioids, and
d treatment of the patient with
pain and psychiatric comorbidities.
d
d

The course has been publicized
through mass mailing to physicians, physician assistants, and
advanced practice nurses. To facilitate attendance for practicing
clinicians across the state, the
course was held on Saturday
mornings at 6 different times and
dates and varying locations in New
Mexico including the Raymond
G. Murphy VA Medical Center, the
University of New Mexico Health
Sciences Center, Las Cruces in
Southern New Mexico, and Santa
Fé in Northern New Mexico. The
course received logistical support
from the University of New Mexico School of Medicine CME ofﬁce
and was funded only through
modest participation fees, with no
funding from external or commercial sources.

d

METHODS
To assess the success of the
educational intervention in improving practice, UNMHSC faculty
conducted a research study. The
short-term objectives for the study
were to determine whether the
course would result in improved
knowledge, self-efﬁcacy, and attitudes for the course participants
regarding pain management and
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opioid or benzodiazepine prescribing when treating patients
with pain and addiction. Longerterm objectives were to consider
the association between educational efforts such as the 1-day
course, the policy and regulatory
initiatives for pain and opioids,
and the prescribing patterns of
New Mexico clinicians including
adoption of best practices recommended in the course. The
broader public health goal of these
efforts in education and regulation
was to achieve a reduction in
prescription opioid deaths in the
state.
During the informed consent
process, we explained the voluntary and anonymous nature of the
study to the participants and assured them that their participation
in the study had no bearing on
their completion of the course or
receipt of continuing education
credit for the course. Clinicians
were surveyed before and after
the 5-hour course by way of 3
different surveys: a 10-item multiple-choice pain and opioid
knowledge questionnaire, a
10-item self-efﬁcacy survey, and
a 12-item attitude survey.
Several course faculty members
developed the 10-item chronic
pain multiple choice knowledge
questionnaire based on the course
content. These knowledge items,
as well as the 10-item self-efﬁcacy
survey, have been used with
community clinicians from New
Mexico who participate in the
University of New Mexico Project
ECHO23,24 Chronic Pain Program.
The KnowPain 12-Attitude
Survey, developed originally as
the KnowPain-50 Survey25 and
then revalidated in short form by

the University of Washington with
support from University of New
Mexico, was implemented to assess change in clinician attitudes in
caring for patients with pain and
addiction.
We collected surveys from 6
courses held between November
3, 2012, and May 18, 2013: 4 in
Albuquerque (the most populated
urban center of the state), 1 in Las
Cruces (Southern New Mexico),
and 1 in Santa Fé (Northern New
Mexico). A pre---post design was
used to compare participants’
knowledge, perceived competence
in chronic pain management, and
attitudes toward caring for patients with pain and addiction at
both the beginning and end of the
course.

RESULTS
Cumulatively, 1090 clinicians
attended the 6 courses. One percent of the attendees opted out of
participating in the study. The
participants included 733 (67%)
physicians (i.e., MD or DO) and
327 (30%) midlevel clinicians (i.e.,
nurse practitioner or physician
assistant). The remaining 30 (3%)
participants included various
health care professionals (e.g.,
DDS, certiﬁed nurse-midwife).
Most physician participants were
trained in primary care specialties
of family medicine and internal
medicine; these are the clinicians
who provide the majority of pain
management in New Mexico.
Pediatricians, psychiatrists, and
emergency clinicians represented
the next largest group of participants (Figure 2).
Survey results comparing preand postcourse scores demonstrated
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FIGURE 2—Most represented University of New Mexico Pain Center Course participants by (a) physician
specialty (n = 733) and (b) profession for nonphysician clinicians (n = 357): November 3, 2012–May 18,
2013.

a signiﬁcant positive change in
knowledge, self-efﬁcacy, and attitudes on the Knowledge Survey,
the Self-Efﬁcacy Survey, and the
KnowPain-12 Survey with large
effect sizes of 1.04, 1.06, and 1.10
for each pre---post comparison
(Table 1). There were also promising trends in terms of the
broader public health objectives
the consortium sought to achieve
through the combined policy and
educational initiative. Although

there were slight increases in
the total numbers of opioid
prescriptions ﬁlled since 2008,
the total morphine milligram
equivalents (MME) of opioids
dispensed continually decreased
since the peak in July---December
2011. In addition, the amount of
opioid MME per prescription also
continued to decline since July--December 2011 (Table 2). This
decline was accompanied by a
shift in prescribing pattern of opioid
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analgesics with a decline in highdose opioid prescriptions (> 100
MME/day) from a high of 14.3%
of all opioid analgesic prescriptions ﬁlled in 2010 to 12.1% in
2013. The lower doses of opioid
analgesics (up to 40 MME/day)
have increased from 49.5% of all
opioid prescriptions ﬁlled in 2010
to 56.9% in 2013.
The total Valium milligram
equivalents of benzodiazepines
dispensed also continued to

decline since the peak in January--June 2011 and dropped to levels
from 2008 PMP data for 2 years;
a reduction in benzodiazepine
prescriptions ﬁlled also was documented. The University of New
Mexico CME course underscored
that the vast majority of overdose
deaths combined opioids with alcohol, benzodiazepines, or other
substances of abuse. The NMMB
requires practitioners to check the
PMP for other controlled substances being prescribed to the
patient. These data suggest that
practitioners have heeded this
warning as benzodiazepine prescriptions also decreased over the
past 2 years (Table 2).
A long-term goal of this educational intervention is to reduce
prescription opioid related deaths
in the state of New Mexico. During
2012, there was a decline in the
total drug overdose death rate
from 25.9 per 100 000 in 2011
to 24.0 per 100 000 in 2012 and
a decrease in the number of
deaths from 521 in 2011 to 485
in 2012. Several additional years
of data from the New Mexico Department of Health will be needed
to assess the relationship between
the educational intervention and
prescription opioid overdose
deaths (Bureau of Vital Records
and Health Statistics, New Mexico
Department of Health, Underlying
Cause of Death).

DISCUSSION
We report here on 1 state’s response to the crises of prescription
opioid misuse and overdose
through a legislatively mandated
CME program designed to have
a positive public health impact on
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TABLE 1—Chronic Pain 1-Day Survey Summary: New Mexico, November 3, 2012–May 18, 2013
Difference
Measure

Precourse
Mean

Postcourse
Mean

No.

Mean (SD)

Student t

P

Effect
Size (d)

Knowledge Survey
Test score (10 possible)

7.04

Percent score (100% possible)

70.4

8.78
87.8

1075

1.74 (1.68)

34.01

< .001

1.04

1075

17.4 (16.8)

34.01

< .001

1.04

Self-Efficacy Survey
Overall rating (7 possible)

4.56

Percent rating (100% possible)
KnowPain-12 Survey

65.2

Overall rating (6 possible)

4.23

Percent rating (100% possible)

5.47
78.1

70.5

4.66
77.8

1073

0.91 (0.85)

34.80

< .001

1.06

1073

12.9 (12.2)

34.80

< .001

1.06

1052

0.44 (0.39)

35.63

< .001

1.10

1052

7.3 (6.6)

35.63

< .001

1.10

Note. Overall rating: tests for significance. Scores were adjusted to be unidirectional for the overall analysis, with the higher number being the
ideal direction of improvement.

prescribing patterns state-wide.
The results demonstrate that an
innovative coalition of an academic
medical center, the state department of health, the medical and
pharmacy licensing boards, the
Project ECHO Institute, and the
state legislature can develop a
mandated CME requirement that

signiﬁcantly impacts the knowledge, attitudes, and self-efﬁcacy of
practitioners with regard to best
practices in pain management and
opioid prescribing.
Additionally, there are early but
encouraging trends that this combined rules- and values-based
approach has contributed to a

reduction in the quantity of
opioid medications prescribed after a 5-year steady increase in
those prescriptions in New Mexico.
The New Mexico Board of Pharmacy data suggest that New Mexico clinicians are adopting the best
practices of prescribing lower
doses of opioids, because higher

doses of opioids are associated
with increased morbidity and
overdose deaths, especially in
chronic pain patients.26 The data
are preliminary to claim that the
efforts of the coalition will achieve
the public health goal of reducing
overdose deaths involving opioids,
which are frequently combined
with benzodiazepines and alcohol.
The study has important limitations. It is possible that other factors have contributed to the decline
in opioid prescribing in New Mexico. Media attention has focused on
the New Mexico prescription opioid crisis as well as prescribers who
have been sanctioned by the Medical Board for excessive opioid
prescribing.27 These news stories
could certainly have inﬂuenced the
opioid prescribing patterns of clinicians. The UNMHSC course was
only one of several educational
programs offered to meet the CME
requirement, although it should
be noted that several of the core
faculty of the UNMHSC Pain

TABLE 2—Prescriptions of Opioid Analgesics and Benzodiazepines: New Mexico Prescription Monitoring Program Data, 2008–2013

Time Period

Opioid
Prescriptions
Filled, No.

Total MME
of Opioids
Dispensed, No.

Opioid MME per
Prescription, No.

Benzodiazepine
Prescriptions
Filled, No.

Total VME of
Benzodiazepines
Dispensed, No.

2008 January–June

748 518

835 798 584

1117

330 192

208 790 533

2008 July–December

748 716

838 432 412

1120

334 092

215 025 059

2009 January–June

782 970

872 458 043

1114

352 051

230 144 820

2009 July–December

783 379

920 667 804

1175

355 856

234 702 614

2010 January–June

803 663

980 218 843

1220

366 773

247 186 367

2010 July–December
2011 January–June

778 050
809 523

985 578 313
972 977 485

1267
1202

351 687
355 233

243 520 952
247 584 917

2011 July–December

880 838

1 039 292,508

1180

380 106

263 125 880

2012 January–June

863 768

998 153 444

1156

365 219

252 794 005

2012 July–December

886 416

969 522 667

1094

362 415

250 480 873

2013 January–June

896 925

926 180 808

1033

358 570

229 931 101

Note. MME = morphine milligram equivalents; VME = Valium milligram equivalents.
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Management course, members of
the Medical and Pharmacy Boards,
and the Governor’s Advisory
Council also participated in several
of these other programs.
Even with these limitations,
the coalition has produced positive
public health beneﬁts. The key prescribing parameters associated with
opioid overdoses and deaths are all
trending downward, including
the number of opioid and
benzodiazepine prescriptions
ﬁlled,
d the total MME of opioids and
Valium milligram equivalents of
benzodiazepines dispensed,
d the number of opioids included
in any single prescription, and
d the opioid MME per prescription
dispensed.
d

These changes in prescribing
patterns may represent clinician
adoption of “best practices” in pain
and addiction that were taught in
the educational intervention. In
2013, the Federation of the State
Medical Boards developed a new
“Model Policy for Use of Opioid
Analgesics in the Treatment of
Chronic Pain,” which identiﬁes the
same objectives taught in the
UNMHSC course on pain and addiction.28
A comparison of the New Mexico Medical Board CME regulations with other states shows that
the New Mexico coalition has
attained these public health goals
without the restriction of physician
autonomy seen in other states.29
No other state has an academic
medical center so integrally involved in the formulation and
implementation of the CME
requirement on pain management. We would argue that the

participation of UNMHSC helped
steer the legislative process to include a primarily educational focus as part of its regulatory trajectory. The intent of the New Mexico
coalition is to avoid the “chilling
effect” noted in other states,
especially among primary care
clinicians treating legitimate
chronic pain patients with opioid
analgesics because of legal and
regulatory ramiﬁcations.13,30 The
New Mexico Board of Pharmacy
prescribing data thus far suggest
that clinicians are not refusing to
prescribe opioids for chronic pain,
but instead are prescribing them
more safely and responsibly.
There are 5 unique aspects of
the New Mexico policy and educational initiative that may account for these positive outcomes.
First—and we think the most
important—is the statutory requirement that pain CME include
education on addiction. Studies
have found that practitioners have
inadequate training in each of
these 2 areas. The fact that there is
insufﬁcient communication and
coordination between the pain
and addiction communities,31,32
and that failure of public health and
subject-matter experts to provide
clear and consistent guidance on the
management of the co-occurring
disorders of pain and addiction,
leaves clinicians with mixed
messages.33
Second, physicians are not the
only practitioners who prescribe
the opioids that are misused and
abused. Currently California, Iowa,
Massachusetts, Tennessee, and
West Virginia require CME speciﬁc
to chronic pain (http://www.fsmb.
org). However, New Mexico is the
only state requiring CME training

August 2014, Vol 104, No. 8 | American Journal of Public Health

on chronic pain and safe opioid
prescribing for all practitioners
with DEA registration.
Third, unlike several other
states that target only primary care
physicians, no medical or surgical
specialty in New Mexico is exempt
from the CME requirement.
Fourth, only New Mexico requires pain CME with each license
renewal. California, for example,
requires only a 1-time, 12-hour
requirement on Pain Management
and End of Life Care (combined).
Fifth, Tennessee is the only
other state that requires both the
querying of the PMP and the
taking of the CME, but whereas
Tennessee requires an annual
PMP inquiry for each patient,
New Mexico mandates that
inquiry every 6 months.29
It is our contention in this article
that the opioid prescribing behaviors of health care professionals
can be positively affected by
mandated education without
mandating prescription limits. We
have described the beneﬁcial outcomes achieved by a coalition of
the boards of medicine and pharmacy, the state legislature, an academic medical center, and Project ECHO Pain in mandating
a 5-hour CME course covering
best practices in chronic pain and
addiction management. The
course improved clinician knowledge, attitudes, and self-efﬁcacy,
and there is emerging evidence
that these improvements have
translated into real-world, positive
changes in practitioner prescribing. It is our hope that these
changes will, in time, stem the
tragic tide of opioid deaths in New
Mexico and provide other states
with an effective alternative in

their own efforts to combat the
chronic pain, addiction, and prescription opioid crises. j
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